Short- and long-term outcomes after heart transplantation in cardiac sarcoidosis and giant-cell myocarditis: a systematic review and meta-analysis

Heart transplantation (HTx) is a valid therapeutic option for end-stage heart failure secondary to cardiac sarcoidosis (CS) or giant-cell myocarditis (GCM). However, post-HTx outcomes in patients with inflammatory cardiomyopathy (ICM) have been poorly investigated. We searched PubMed, Scopus, Scienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobbio, Emanuele, Björkenstam, Marie, Nwaru, Bright I., Giallauria, Francesco, Hessman, Eva, Bergh, Niklas, Polte, Christian L., Lehtonen, Jukka, Karason, Kristjan, Bollano, Entela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816313/
https://www.ncbi.nlm.nih.gov/pubmed/34402927
http://dx.doi.org/10.1007/s00392-021-01920-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816313/
https://www.ncbi.nlm.nih.gov/pubmed/34402927
http://dx.doi.org/10.1007/s00392-021-01920-0

Ejemplares similares